| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 06/18/1997 | EP0779284A1 Novel 2-naphthamide derivatives and their use in therapy as D3 receptor agonists |
| 06/18/1997 | EP0779075A1 Use of 3-alpha-hydroxy-5alpha-androsta-16-ene as pharmaceutical |
| 06/18/1997 | EP0778836A1 Substituted 9-alkyladenines |
| 06/18/1997 | EP0778834A1 Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2 |
| 06/18/1997 | EP0778833A1 Endothelin receptor antagonists |
| 06/18/1997 | EP0494264B1 Inhibiting transforming growth factor to prevent accumulation of extracellular matrix |
| 06/17/1997 | US5639902 (Cyclohexyl)alkene compounds |
| 06/17/1997 | US5639796 Injectable medical composition and method of use |
| 06/17/1997 | US5639727 Therapeutic uses of bactericidal/permeability increasing protein products |
| 06/17/1997 | US5639638 DNA molecules encoding bone morpogenetic protein-11 |
| 06/12/1997 | WO1997020811A1 Vitamin d analogues |
| 06/12/1997 | WO1997020574A1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling |
| 06/12/1997 | CA2770851A1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling |
| 06/12/1997 | CA2239448A1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling |
| 06/11/1997 | EP0778284A2 New 7-beta-substituted-4-aza-5alpha-androstan-3-ones as 5alpha-reductase inhibitors |
| 06/11/1997 | EP0778277A1 Substituted heterocyclic derivatives as CRF antagonists |
| 06/11/1997 | EP0777684A1 Calcitonin receptor |
| 06/11/1997 | EP0777661A1 Natriuretic and anti-hypertensive compounds |
| 06/11/1997 | EP0777493A1 Calcitonin gene related peptide receptor |
| 06/11/1997 | EP0777481A1 Use of n-substituted phenothiazines |
| 06/11/1997 | EP0777476A1 Methods of inhibiting endometrial cancer |
| 06/11/1997 | EP0777469A1 Use of insulin sensitisers for treating renal diseases |
| 06/11/1997 | EP0700395B1 Indole derivatives as steroid 5-alpha-reductase inhibitors |
| 06/11/1997 | EP0656786A4 Health supplements containing phyto-oestrogens, analogues or metabolites thereof. |
| 06/11/1997 | CN1151758A Novel growth of differentiation factor of the TGF- 'beta' family |
| 06/10/1997 | US5637712 Process of preparing isoquinoline compounds |
| 06/10/1997 | US5637470 Screening array using cells expressing recombinant α and β subunits of the mammalian large-conductance (maxi-K) potassium channel |
| 06/05/1997 | WO1997019942A1 5-azabicyclo(3.1.0)hexylalkyl-2-piperidones and -glutarimides as neurokinin receptor antagonists |
| 06/05/1997 | WO1997019914A1 Amino acid derivatives, medicaments containing said compounds and methods of producing said compounds |
| 06/05/1997 | DE19544686A1 Aminosäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung Amino acid derivatives, medicaments containing these compounds and processes for their preparation |
| 06/04/1997 | EP0776325A1 Novel use and novel derivatives of imidazole, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same |
| 06/04/1997 | EP0776207A1 Use of zaprinast for the manufacture of a medicament for the treatment of acute renal failure |
| 06/04/1997 | EP0559690B1 8-ENE-19, 11 beta-BRIDGED STEROIDS, THEIR PREPARATION AND PHARMACEUTICAL FORMULATIONS CONTAINING THEM |
| 06/04/1997 | CN1151164A Sterol derivatives used for regulation of meiosis |
| 06/04/1997 | CN1151154A Novel antitumor and antileukemia substanes, preparation thereof and pharmaceutical compositions containing same |
| 06/04/1997 | CN1151116A Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies |
| 06/04/1997 | CN1035056C Method for preparing cyclic neurokinin A antagonists |
| 06/04/1997 | CN1035055C Process for preparaing unsaturated 17-'beta' substituted 3-carboxysteroids |
| 06/03/1997 | US5635537 8-substituted-2-aminotetralins |
| 06/03/1997 | US5635528 Intermediates to tetrahydro-beta-carbolines |
| 06/03/1997 | US5635516 (Thia) cycloalkyl[B]indole compounds as anti-inflammatory agents |
| 06/03/1997 | US5635504 Diazepine containing dual action inhibitors |
| 06/03/1997 | US5635502 Mercaptoacetylamide bicyclic lactam derivatives useful as inhibitors of enkephalinase and ACE |
| 06/03/1997 | US5635498 Method of controlling male fertility |
| 05/29/1997 | WO1997019095A1 6-0-methyl erythromycin d and process for making |
| 05/29/1997 | WO1997019064A1 Novel fluorinated or hydroxylated phenylimidazolidines having anti-androgenic activity, method for preparing same, resulting intermediates, and pharmaceutical compositions |
| 05/29/1997 | WO1997018838A1 Therapeutic uses of humanized antibodies against alpha-4 integrin |
| 05/29/1997 | WO1997018813A1 Inhibitors of farnesyl-protein transferase |
| 05/29/1997 | CA2238081A1 Inhibitors of farnesyl-protein transferase |
| 05/29/1997 | CA2237808A1 Therapeutic uses of humanized antibodies against alpha-4 integrin |
| 05/29/1997 | CA2237472A1 6-0-methyl erythromycin d and process for making |
| 05/28/1997 | EP0775742A2 Inhibiting transforming growth factor beta to prevent accumulation of axtracellular matrix |
| 05/28/1997 | EP0775132A1 (azetidin-1-ylalkyl)lactams as tachykinin antagonists |
| 05/28/1997 | EP0775118A1 Benzimidazole derivatives having dopaminergic activity |
| 05/28/1997 | EP0774965A1 Phenoxyphenylacetic acid derivatives |
| 05/28/1997 | CN1150799A Benzoheterocyclic derivatives |
| 05/28/1997 | CN1150759A Dialysis fluid containing peptides obtained from casein as osmotic agents and bicarbonate ions as buffering agents |
| 05/28/1997 | CN1035006C Method for preparing peptide of effect having bradykinin-antagonistic agent |
| 05/27/1997 | US5633276 Melatonin system disorders |
| 05/27/1997 | US5633147 Transforming growth factor αH1 |
| 05/22/1997 | WO1997018223A1 Improved method and agents for inhibiting protein aging |
| 05/22/1997 | WO1997017967A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS |
| 05/22/1997 | CA2237565A1 Improved method and agents for inhibiting protein aging |
| 05/21/1997 | EP0774459A1 Sulfonylamino-substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic agent as well as medicament containing them |
| 05/21/1997 | EP0774458A1 Substituted benzodicarboxylic acid diguanidines, process for their preparation, and their use as medicament or diagnostic agent |
| 05/21/1997 | EP0774457A1 Substituted benzodicarboxylic acid diguanidines, process for their preparation, and their use as medicament or diagnostic agent |
| 05/21/1997 | EP0773927A2 Benzoylguanidine derivatives as medicaments |
| 05/21/1997 | EP0773790A1 Invariant chain compositions useful for treating autoimmune diseases |
| 05/21/1997 | EP0773787A1 HLA binding peptides and their uses |
| 05/21/1997 | EP0674509A4 Methods for treatment with dimercaptosuccinic acid (dmsa). |
| 05/21/1997 | EP0472725B1 Treatment of polycystic ovarian disease |
| 05/21/1997 | CN1150041A Chinese patent medicine for curing gallstones and kidney stones |
| 05/21/1997 | CA2190693A1 Substituted benzenedicarboxylic acid diguanides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 05/21/1997 | CA2190692A1 Substituted benzenedicarboxylic acid diguanides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 05/20/1997 | US5631293 Cardiovascular disorders |
| 05/20/1997 | US5631279 Antagonists of neurokinin a |
| 05/20/1997 | US5631269 Pyrazole, isooxazole or isothiazole piperidine derivatives |
| 05/20/1997 | US5631260 Xanthine epoxides as A1 adenosine receptor agonists and antagonists |
| 05/20/1997 | US5631247 Antilipemic agents, cardiovascular disorders, urogenital disorders and osteoporosis |
| 05/15/1997 | WO1997017340A1 Novel imidazole derivatives, method for preparing same, resulting intermediates, pharmaceutical compositions and use of said derivatives as endothelin antagonists |
| 05/15/1997 | WO1997017067A1 Sublingual and buccal administration of selegiline |
| 05/15/1997 | CA2190220A1 Sulfonylamino-substituted benzoylguanidines, a process for their preparation, their use as medicament of diagnostic aid, and medicament containing them |
| 05/14/1997 | EP0773024A2 Use of N-substituted nicotinamide compounds for the treatment of acute and chronic inflammatory diseases |
| 05/14/1997 | EP0772610A1 Dihydrobenzofuranes |
| 05/14/1997 | EP0772450A1 Methods for treating bleeding disorders |
| 05/14/1997 | EP0772441A1 Use of a progesterone antagonist and of a gestagen for the treatment of endometriosis or leiomyomata uteri |
| 05/14/1997 | CN1149583A Enderma agent receptor antagonist |
| 05/13/1997 | US5629318 Method of treatment of chronic prostatitis with 17β-N-monosubstituted-carbamoyl-4-aza-5α-androst-1-en-3-ones |
| 05/13/1997 | US5629315 Treatment of psoriasis, asthma,osteoporosis, alcoholic hepatitis, and premature labor |
| 05/13/1997 | CA2132045C Pharmaceutical composition for prophylaxis and treatment of premature ejaculation |
| 05/09/1997 | WO1997016729A1 Combinatorial dihydrobenzopyran library |
| 05/09/1997 | WO1997016434A1 (-) cis-6(s)-phenyl-5(r)[4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol d-tartrate |
| 05/09/1997 | WO1997016430A1 Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases |
| 05/09/1997 | WO1997016206A1 Bladder nuclear matrix proteins and their use in detecting and treating cell proliferative disorders |
| 05/09/1997 | WO1997016185A2 A pharmaceutical composition for the treatment of autoimmune diseases |
| 05/09/1997 | CA2234641A1 Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases |
| 05/09/1997 | CA2209314A1 Bladder nuclear matrix proteins and their use in detecting and treating cell proliferative disorders |
| 05/07/1997 | EP0771799A1 Purin-6-one derivatives |
| 05/07/1997 | EP0771788A2 Substituted sulphonimidamides, method for their preparation, their use as medicament or diagnostic and medicament containing them |
| 05/07/1997 | EP0771216A1 Methods and compositions for the specific coagulation of vasculature |